Factitious Hyperkalemia in Dogs With Thrombocytosis
نویسندگان
چکیده
منابع مشابه
Thrombocytosis in 715 Dogs (2011–2015)
BACKGROUND Thrombocytosis is a hematologic abnormality in dogs that has been associated with various neoplastic, metabolic, and inflammatory conditions. OBJECTIVE To classify thrombocytosis in dogs based on severity and evaluate whether there are associations between severity and underlying disease processes. ANIMALS Seven hundred and fifteen dogs with thrombocytosis and 1,430 dogs with nor...
متن کاملJak-2 mutation frequency in patients with thrombocytosis
Background: We aimed to investigate the etiologic causes and the existence of Janus kinase 2 mutation (JAK2) in cases with thrombocytosis. Methods: In this retrospective study, patients, who were admitted to hematology clinic with thrombocytosis between 2013 and 2015, were investigated in terms of the etiological causes of thrombocytosis and the existence of JAK2 mutation. Results: We retrospe...
متن کاملFactitious disorder in adolescence.
Factitious disorder (FD) is defined as a condition in which a person voluntarily produces symptoms or illness and acts as if they are ill without an external gain (1). In the Psychiatric Disorders Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), it is divided into three types as “Factitious disorders with predominantly psychological signs and symptoms”, “Factitious disorders with...
متن کاملFactitious hypoglycemia in patients with leukemia.
In 1927, Falcon-Lesses reported on the rapid disappearance in vitro of glucose in blood removed from patients with leukemic leukocytosis. He demonstrated complete disappearance of glucose from the blood of patients with both myelogenous and lymphocytic leukemia within \tyi to 4 hr. after the blood was drawn. He took great care not to inhibit glycolysis in the blood samples removed from his pati...
متن کاملThrombocytosis.
Major progress in understanding the pathogenesis in patients with thrombocytosis has been made by identifying mutations in the key regulators of thrombopoietin: the thrombopoietin receptor MPL and JAK2. Together, these mutations can be found in 50% to 60% of patients with essential thrombocythemia or primary myelofibrosis and in 10% to 20% of hereditary thrombocytosis. A decrease in expression ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Veterinary Internal Medicine
سال: 1989
ISSN: 0891-6640,1939-1676
DOI: 10.1111/j.1939-1676.1989.tb00328.x